Healthy Aging: Helminths as a New Lead

Living longer matters less than living longer in good health, and the chronic low-grade inflammation of aging (inflammaging) is a major obstacle. Two recent studies show that type 2 immunity, which helminths trigger naturally, acts all the way into the bone marrow. Fagnan et al. (Nature, 2026) describe in mice an emergency type 2 myelopoiesis, triggered by IL-33 through the LMO4-GATA2 axis, which steers progenitors toward basophils, eosinophils and mast cells. Yao et al. (Immunity, 2026) show that IL-4 restores lymphocyte production and improves the performance of aged mice. Together these results suggest that a helminth could sustain an endogenous brake on inflammaging. A 2018 experiment in CBA mice, in which early inoculation with Heligmosomoides polygyrus shortened lifespan, seems to contradict this hypothesis. This review explains why it did not test it (a strain with a weak type 2 response, a single inoculation), proposes better-designed preclinical studies (regular re-inoculations, responder strains, normal microbiota, models closer to Necator americanus) and discusses dosing schedules for helminthic therapy clinical trials.French version: https://doi.org/10.5281/zenodo.24202673

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-13
DOI
https://doi.org/10.5281/zenodo.24202671
Primary Topic
Parasites and Host Interactions
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Healthy Aging: Helminths as a New Lead

Jacques Le Marois
Zenodo (CERN European Organization for Nuclear Research)
Parasites and Host Interactions
preprint

Healthy Aging: Helminths as a New Lead

Jacques Le Marois
preprint en

Abstract

Living longer matters less than living longer in good health, and the chronic low-grade inflammation of aging (inflammaging) is a major obstacle. Two recent studies show that type 2 immunity, which helminths trigger naturally, acts all the way into the bone marrow. Fagnan et al. (Nature, 2026) describe in mice an emergency type 2 myelopoiesis, triggered by IL-33 through the LMO4-GATA2 axis, which steers progenitors toward basophils, eosinophils and mast cells. Yao et al. (Immunity, 2026) show that IL-4 restores lymphocyte production and improves the performance of aged mice. Together these results suggest that a helminth could sustain an endogenous brake on inflammaging. A 2018 experiment in CBA mice, in which early inoculation with Heligmosomoides polygyrus shortened lifespan, seems to contradict this hypothesis. This review explains why it did not test it (a strain with a weak type 2 response, a single inoculation), proposes better-designed preclinical studies (regular re-inoculations, responder strains, normal microbiota, models closer to Necator americanus) and discusses dosing schedules for helminthic therapy clinical trials.French version: https://doi.org/10.5281/zenodo.24202673

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Parasites and Host Interactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon